Pioneering phase 2 clinical trial for glioblastoma delivers initial results. While no survival breakthroughs yet, this groundbreaking adaptive platform trial brings hope for efficient therapy identification.
Researchers achieved a breakthrough in bladder cancer by identifying novel biomarkers that detect the disease at an early stage. They utilized advanced genomic techniques to pinpoint genetic mutations linked to bladder cancer. Additionally, innovative immunotherapies targeting specific molecular pathways exhibited promising results in clinical trials, enhancing treatment efficacy and patient outcomes. This multifaceted approach has […]
The new study suggesting that cancer screening may not extend lives is considered flawed. While the study might raise questions about the effectiveness of cancer screening, experts point out several limitations, such as potential biases and methodological issues, that could influence its conclusions. They argue that a more comprehensive and rigorous analysis of the available […]
Novel pancreatic cancer organoids offer a groundbreaking platform for screening anticancer drugs. By replicating the characteristics of actual tumors, these 3D models simulate the behavior and responses of pancreatic cancer cells to various treatments. This innovation allows scientists to test potential drugs more accurately, predicting their efficacy and potential side effects in a more realistic […]
